SureStart™ LactoB HN001™

An extensively studied probiotic, SureStart™ LactoB HN001™ supports immunity and health for mothers, infants and young children.

Lacticaseibacillus rhamnosus HN001*  

Features:

  • Freeze-dried powder
  • Specifications are available for powders or dry supplements
  • For maternal and paediatric applications
  • Flavourless
  • Vegetarian, Halal and Kosher
  • Non-GMO Project Verified
  • New Zealand origin

Our Sustainability Story*:

Disclaimer: While we try to represent product images accurately, the representation on your screen may be different to the actual product for various reasons.

Disclaimer: While we try to represent product images accurately, the representation on your screen may be different to the actual product for various reasons.

Explore applications

Infant Nutrition

Boosts infant immunity

A strong immune system relies on well-balanced gut microbiome.  Probiotics are good bacteria that can help support the development and maintenance of a healthy immune system. 

 

Not all probiotics are proven to have the same benefits. Awareness of the specific benefits of particular probiotic strains and education on product efficacy is increasing. Fonterra probiotics are clinically tested to provide immune protection and other health benefits.  

The incidence of food allergies is growing

Prevalence of food allergies is a growing health concern, not only in Western countries but in rapidly developing countries.  In China, rising C-section rates, antibiotics abuse, and air pollution are placing babies at increased risk of allergies.

 

NZ Clinical Study: In a two-year clinical trial with 425 infants aged 0-24 months, supplementation with SureStart™ LactoB HN001™ demonstrated:

  • long term protection against eczema
  • reduced risk of respiratory allergies, an
  • extended beyond the treatment period and up to 11 years of age (ongoing follow-up)

Health during pregnancy is important for both mother and baby

The right nutrition is an important part of maintaining health and wellbeing.  Emerging evidence suggests SureStart™ LactoB HN001™ helps to reduce the risk of gestational diabetes and postnatal depression when taken during pregnancy and breastfeeding.

 

Gestational diabetes is a severe and neglected threat to maternal and child health

Gestational diabetes mellitus (GDM) occurs during pregnancy and can affect the health of mother and baby.

 

Complications include uncontrolled blood sugar levels, high blood pressure (preeclampsia) and a typically larger baby.  It is estimated that GDM affects 7-10% of all pregnancies worldwide.4 More than half of women with a history of GDM develop type 2 diabetes within 5-10 years post-birth.  

Depression during and after pregnancy is a common and serious condition

Depression is a mental illness affecting 322 million people worldwide, and as much as a third of the Chinese population5. Women are more vulnerable to depression, and this intensifies during and after pregnancy.

 

It is not uncommon for mothers to suffer from baby blues after having a baby.  Generally, this will last a day or two, whereas postnatal depression is a more serious condition, that not only impacts the mother (often causing stress and anxiety) but can reduce bonding with the baby. 

Globally, 10% of pregnant women and 13% of women post-birth experience a mental health problem.5 In China, 6-28% of women suffer from depression during pregnancy, while 10-28% suffer postnatal depression5.

NZ Clinical Study: A study with 423 pregnant women taking SureStart™ LactoB HN001™ from the second trimester until 6 months following birth demonstrated:

  • Reduced prevalence of Gestational Diabetes Mellitus (GDM) during pregnancy, and 
  • Significantly reduced symptoms of postnatal depression and anxiety.

 

SureStart™ is NZMP's brand for Paediatric Nutrition

Key benefits

Allergy protection

Reduces infant and childhood eczema symptoms by 50%. Provides long-lasting protective benefits with reduced eczema and hay fever up to 11 years.

Immunity protection

Improved immune protection via strengthened gut integrity. Enhances immune biomarker measures.

Maternal health & wellbeing

Has the potential to support emotional balance post pregnancy by reducing postnatal depression and anxiety. Potential to reduce the incidence of Gestational Diabetes Mellitus (GDM) in high-risk groups.

Effective and safe

Backed by 100+ peer-reviewed publications and over 90 years of probiotic heritage. Approved for use in foods for infants and children in China.

Superior shelf-life stability

High survival rates in typical powdered applications, enabling a lower addition rate to deliver a competitive cost in use.

Technical expertise

Unlocks access to industry leading formulation and application support to reduce development time.

Title

Please add a copy here.

Please Drag & Drop Background Image from Toggle Side Panel > Assets

Resources

Product Summary: SureStart™ LactoB HN001™
Publication List: SureStart™ BifidoB HN019™
Whitepaper #1: The Probiotic Effect
Whitepaper #2: Stimulating the Body's Defences

  • [1] Tang et.al 2018, The Epidemiology of Food Allergy in The Global Context.
  • [2] Gao et.al Prevalence of GDM in mainland China: A systematic review and meta-analysis, 2019.
  • [3] International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017.
  • [4] Behboudi-Gandevani et.al, The impact of diagnostic criteria for GDM on its prevalence: as systematic review and meta-analysis, 2019.
  • [5] The Effect of Maternal Depression on Infant Attachment: A Systematic Review Int. J. Environ. Res. Public Health 2020, 17, 2675; doi:10.3390/ijerph17082675.
Please Drag & Drop Background Image from Toggle Side Panel > Assets
Important Disclaimer:  NZMP (and the Fonterra Group) makes no representations or warranties in respect of the information contained on the NZMP website or on this particular webpage, including representations or warranties (express or implied) concerning fitness for purpose or appropriateness (including whether such information can be used in compliance with any applicable jurisdiction) in relation to the use in connection with the marketing, promotion and sale of any third party products. Without limiting the foregoing, any use of, or reliance on, the information contained on the NZMP website or on this particular webpage is not the responsibility of NZMP or the Fonterra Group.
*Note:  Without limiting the Important Disclaimer above, please note that the use of, or reliance on, any claims related to our “Our Sustainability Story” is not the responsibility of NZMP or the Fonterra Group. Please reach out to us if you are interested in learning more about leveraging our suite of Natural Dairy Claims.
This information is designed to give a brief overview of the nature and characteristics of our products as at the date of preparation. It does not constitute representations or warranties as to such characteristics, the functionality or potential applications of our products. You must assure yourself of these matters having regard to our detailed product specifications, your specific circumstances and market requirements.

* In April 2020 the Lactobacillus genus was reclassified, resulting in a name change of our probiotic from Lactobacillus rhamnosus HN001 to Lacticaseibacillus rhamnosus HN001. There is no change to the abbreviated scientific notation L.rhamnosus HN001. Additional information can be found here

How can we help?

Receive the latest NZMP news, insights & updates direct to your inbox